Healthtech Startups

Arsipa is a group of occupational medicine and workplace safety providers offering companies preventive health services and safety management (Grundbetreuung and betriebsspezifische Betreuung per DGUV V2). It serves employers across Germany and Austria with on-site care through a network of local specialists.

1 investor

Artax Biopharma is a Phase 2 clinical-stage biotechnology company developing first-in-class oral small-molecule Nck modulators that target T cell receptor Signal 1 activation to treat autoimmune diseases without causing immunosuppression. Its lead candidate AX-158 has shown Phase 2a data in psoriasis, with additional Phase 2 trials planned in atopic dermatitis and rheumatoid arthritis.

1 investor

Arterius develops next-generation, patient-centric medical devices, currently focused on treatments for peripheral arterial disease. The company has created two advanced polymer platforms used in devices to manage arterial disease without leaving long-term implants in the body.

1 investor

Arteryex combines blockchain and AI technology to leverage underutilized health data for personalized healthcare management and medical services. The company targets the Japanese healthcare market, aiming to address the gap between average lifespan and healthy lifespan through optimized health and medical solutions.

1 investor

ArtesRx is a behavioral health long-term care pharmacy organization that operates a network of community-based pharmacies serving patients with complex medication needs, particularly those managing mental illness and substance use disorders.

1 investor

Articulus Surgical develops minimally invasive surgical robotic systems designed for India's Tier 2 and Tier 3 hospitals, where infrastructure and space are constrained. The company builds patient and surgeon-centric robotic platforms optimized for resource-limited surgical environments.

1 investor

Artidis develops nanomechanical imaging technology for rapid cancer diagnosis and treatment optimization in clinical settings. The company's diagnostic platform aims to help clinicians with faster, more accurate cancer assessment and prognosis.

1 investor

Artielle Immunotherapeutics develops DRhQ, a therapeutic platform that targets the CD74 receptor and inhibits macrophage migration inhibitory factor (MIF) to treat neuroinflammatory conditions such as progressive multiple sclerosis and advanced cancers. The company builds on research from OHSU and the VA Portland Healthcare System.

1 investor

ArtiFex Medical develops vascular grafts made from bacterial cellulose for small-diameter vascular access. The company provides a biocompatible material solution for vascular applications in the medical device sector.

1 investor

ARTIS Ventures is a venture capital firm investing in frontier technologies and breakthroughs primarily at the intersection of technology, biology, and healthcare. The firm backs early-stage companies across biotech, life sciences, and health technology sectors, with a portfolio spanning therapeutics, digital health, and medical devices.

1 investor

SocialRx connects members with non-clinical, community-based activities in art, culture, nature, and movement to address mental health and loneliness. The company operates a social prescribing solution serving populations with barriers to traditional mental health care across the United States.

1 investor

Arul Health is building a patient navigation service that bridges healthcare and social care, helping people with serious diagnoses coordinate care, advocate on their behalf, and contest costs. It supports patients and their families through the practical and emotional challenges of illness.

1 investor

Arva is a fertility care provider that combines fertility testing, doctors, nutrition, and treatment including diagnostics, embryology, and IVF under one roof. It serves couples seeking fertility care in India, with an in-clinic location in Indiranagar, Bangalore and at-home options available anywhere in India.

1 investor

Arvida operates retirement villages and aged care facilities in New Zealand. The company is governed by a board of directors and an executive leadership team responsible for its operations.

1 investor

ARxVision makes a wearable AI headset and accessories designed to assist blind and low-vision users by describing their surroundings, reading documents, and providing hands-free audio interaction. Its iOS adapter connects the ARx headset to iPhones with USB-C ports and works with the Prompt Genius app to let users query their environment using customizable AI prompts.

1 investor

Arxada develops microbial control and antimicrobial technologies for professional hygiene, paints, coatings, wood protection, home and personal care, and human health applications. The company serves industrial and consumer end markets with chemistry-based solutions that support product safety and performance.

1 investor

Aryv operates a non-emergency medical transportation (NEMT) service, connecting drivers with passengers who need rides to and from medical appointments. It uses a driver pay model and works with brokers such as MTM, with operations in states including Wisconsin and Florida.

1 investor

Asahi Surgical Robotics develops and manufactures surgical support robotic systems for medical facilities. The company focuses on improving quality of life for patients, families, and healthcare professionals through medical device innovation.

1 investor

Ascelia Pharma is a biotech company developing and commercializing drugs for rare, orphan oncology-related conditions with unmet medical needs. Its clinical-stage pipeline includes Orviglance, an oral MRI contrast agent for detecting liver lesions, and Oncoral, an oral chemotherapy tablet for gastric cancer.

1 investor

Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) that provides formulation, nanotechnology, and manufacturing services for pharmaceutical and biological companies from pre-formulation through commercialization. The company specializes in solving drug development challenges for small molecules, biologics, and gene delivery applications.

1 investor

Ascend Partners is a healthcare investment firm that provides capital and operational support to physician-led companies and healthcare providers serving underserved communities. The firm partners with entrepreneurs to improve care quality, access, and affordability through integrated care delivery models and data-driven population health management.

1 investor

Ascenix provides software for long-term care and nursing facilities that captures, classifies and tracks resident incidents such as falls, pressure injuries, hydration shortfalls and behavioral events across units. The system consolidates documented triggers, repositioning and wound assessments to support care teams in monitoring resident safety.

1 investor

Ascidian Therapeutics is a biotechnology company developing RNA-based therapeutics, with a clinical focus that includes ophthalmology and inherited retinal diseases.

1 investor

Asclepius MedTech supports health technology companies with market access strategy and value proposition development for entering the NHS, drawing on NHS finance and decision-making expertise.

1 investor